Aralez Pharma (ARLZ) Reports Q4 Loss of $0.48/Share

Aralez Pharma (NASDAQ: ARLZ) reported Q4 EPS of ($0.48), versus ($0.40) reported last year. Revenue for the quarter came in at $20 million, versus $6 million reported last year.

GUIDANCE:

Aralez Pharma sees FY2017 revenue of $80-100 million.

For earnings history and earnings-related data on Aralez Pharma (ARLZ) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
• Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance